MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines Journal Article


Authors: Yang, B.; O'Herrin, S. M.; Wu, J.; Reagan-Shaw, S.; Ma, Y.; Bhat, K. M. R.; Gravekamp, C.; Setaluri, V.; Peters, N.; Hoffmann, F. M.; Peng, H.; Ivanov, A. V.; Simpson, A. J. G.; Longley, B. J.
Article Title: MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines
Abstract: The MAGE-A, MAGE-B, and MAGE-C protein families comprise the class-I MAGE/cancer testes antigens, a group of highly homologous proteins whose expression is suppressed in all normal tissues except developing sperm. Aberrant expression of class I MAGE proteins occurs in melanomas and many other malignancies, and MAGE proteins have long been recognized as tumor-specific targets; however, their functions have largely been unknown. Here, we show that suppression of class I MAGE proteins induces apoptosis in the Hs-294T, A375, and S91 MAGE-positive melanoma cell lines and that members of all three families of MAGE class I proteins form complexes with KAP1, a scaffolding protein that is known as a corepressor of p53 expression and function. In addition to inducing apoptosis, MAGE suppression decreases KAP1 complexing with p53, increases immunoreactive and acetylated p53, and activates a p53 responsive reporter gene. Suppression of class I MAGE proteins also induces apoptosis in MAGE-A-positive, p53wt/wt parental HCT 116 colon cancer cells but not in a MAGE-A-positive HCT 116 p53-/- variant, indicating that MAGE suppression of apoptosis requires p53. Finally, treatment with MAGE-specific small interfering RNA suppresses S91 melanoma growth in vivo, in syngenic DBA2 mice. Thus, class I MAGE protein expression may suppress apoptosis by suppressing p53 and may actively contribute to the development of malignancies and by promoting tumor survival. Because the expression of class I MAGE proteins is limited in normal tissues, inhibition of MAGE antigen expression or function represents a novel and specific treatment for melanoma and diverse malignancies. ©2007 American Association for Cancer Research.
Keywords: controlled study; protein expression; unclassified drug; human cell; dna-binding proteins; animals; mice; cell viability; melanoma; apoptosis; protein binding; hct116 cells; cell line, tumor; protein p53; transcription factors; nuclear proteins; gene expression regulation, neoplastic; antigens, neoplasm; melanoma antigen 1; cancer cell; gene repression; cell growth processes; melanoma cell; melanoma, experimental; tumor suppressor protein p53; repressor proteins; scaffold protein; mice, inbred dba; protein mage a; protein mage b; protein mage c
Journal Title: Cancer Research
Volume: 67
Issue: 20
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2007-10-15
Start Page: 9954
End Page: 9962
Language: English
DOI: 10.1158/0008-5472.can-07-1478
PUBMED: 17942928
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 49" - "Export Date: 17 November 2011" - "CODEN: CNREA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew John Simpson
    31 Simpson